ICU · Resuscitation
Anaphylaxis in the ICU
Also known as Anaphylactic shock · Refractory anaphylaxis · Biphasic anaphylaxis · Intravenous adrenaline · Glucagon for beta-blocked anaphylaxis
Anaphylaxis is a severe, life-threatening systemic hypersensitivity reaction. Diagnosis: NIAID/FAAN clinical criteria — acute onset after a likely allergen with skin or mucosal involvement plus respiratory compromise, hypotension, or end-organ dysfunction. Management: IM adrenaline into the anterolateral thigh (adult dose 0.01 mg/kg to a maximum of 0.5 mg, repeated every 5 minutes in life-threatening anaphylaxis), supine with legs elevated, high-flow oxygen, aggressive IV crystalloid. Refractory: IV adrenaline infusion after 2 to 3 IM doses; IV glucagon if beta-blocked (guideline recommendation despite limited evidence); vasopressin, methylene blue and ECMO as rescue. Biphasic reactions: median onset 11 hours (range 0.2 to 72 hours) — observe at least 6 hours; 6 to 12 hours practical. Paired tryptase: acute 30 minutes to 2 hours from onset, baseline at least 24 hours after resolution. Common triggers: drugs (antibiotics, NMBAs), foods, insect stings, radiocontrast.
Practise this topic
On this page
Study tools
Your progress
Saved on this device.
Target exams
Red flags
- IM adrenaline is FIRST-LINE — give EARLY, repeat every 5 minutes. Do NOT delay for IV access
- Beta-blocked patient not responding to adrenaline: give IV GLUCAGON — the guideline-recommended rescue despite limited evidence
- Biphasic reactions recur a median of 11 hours later (range 0.2 to 72 hours) — observe at least 6 hours; 6 to 12 hours is practical
- Do NOT give IM adrenaline slowly or IV undiluted — risk of VF
Meet the patient
A 55-year-old woman receives IV co-amoxiclav and rocuronium for induction of anaesthesia for elective cholecystectomy. Within 2 minutes she becomes hypotensive (BP 65/35), tachycardic (HR 130), develops widespread urticaria, and has audible wheeze with SpO2 falling to 85 per cent. This is perioperative anaphylaxis.[1]
The two questions that decide her next minute are the two that decide every anaphylaxis: is this anaphylaxis? and have I given adrenaline yet? The first is answered by the NIAID and FAAN clinical criteria (the three-criterion table below). The second is always the same: IM adrenaline into the anterolateral thigh now — the standard approved adult dose is 0.01 mg/kg with a maximum of 0.5 mg.[5][32][26]
References32ShowHide
- [1]Brown SG Anaphylaxis: clinical concepts and research priorities Emerg Med Australas, 2006.PMID 16669942
- [2]Shaker MS, Wallace DV, Golden DBK, et al. Anaphylaxis-a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis J Allergy Clin Immunol, 2020.PMID 32001253
- [3]Pouessel G, Dribin TE, Tacquard C, et al. Management of Refractory Anaphylaxis: An Overview of Current Guidelines Clin Exp Allergy, 2024.PMID 38866583
- [4]Lee S, Bellolio MF, Hess EP, et al. Time of Onset and Predictors of Biphasic Anaphylactic Reactions: A Systematic Review and Meta-analysis J Allergy Clin Immunol Pract, 2015.PMID 25680923
- [5]Sampson HA, Muñoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium J Allergy Clin Immunol, 2006.PMID 16461139
- [6]Kim TH, Yoon SH, Hong H, et al. Duration of Observation for Detecting a Biphasic Reaction in Anaphylaxis: A Meta-Analysis Int Arch Allergy Immunol, 2019.PMID 30763927
- [7]Lee S, Sadosty AT, Campbell RL Update on biphasic anaphylaxis Curr Opin Allergy Clin Immunol, 2016.PMID 27253484
- [8]Dribin TE, Sampson HA, Camargo CA Jr, et al. Persistent, refractory, and biphasic anaphylaxis: A multidisciplinary Delphi study J Allergy Clin Immunol, 2020.PMID 32853640
- [9]Harper NJN, Cook TM, Garcez T, et al. Anaesthesia, surgery, and life-threatening allergic reactions: management and outcomes in the 6th National Audit Project (NAP6) Br J Anaesth, 2018.PMID 29935569
- [10]Cook TM, Harper NJN, Garcez T, et al. Anaesthesia, surgery, and life-threatening allergic reactions: epidemiology and clinical features of perioperative anaphylaxis in the 6th National Audit Project (NAP6) Br J Anaesth, 2018.PMID 29935567
- [11]Kemp HI, Cook TM, Thomas M, Harper NJN UK anaesthetists' perspectives and experiences of severe perioperative anaphylaxis: NAP6 baseline survey Br J Anaesth, 2017.PMID 28498889
- [12]Ebo DG, Van Gasse AL, Decuyper II, et al. Acute Management, Diagnosis, and Follow-Up of Suspected Perioperative Hypersensitivity Reactions in Flanders 2001-2018 J Allergy Clin Immunol Pract, 2019.PMID 30857939
- [13]Dejoux A, de Chaisemartin L, Bruhns P, et al. Neuromuscular blocking agent induced hypersensitivity reaction exploration: an update Eur J Anaesthesiol, 2023.PMID 36301083
- [14]Pouessel G, Tacquard C, Tanno LK, et al. Anaphylaxis mortality in the perioperative setting: Epidemiology, elicitors, risk factors and knowledge gaps Clin Exp Allergy, 2024.PMID 38168878
- [15]Sheikh A, Shehata YA, Brown SG, Simons FE Adrenaline for the treatment of anaphylaxis: cochrane systematic review Allergy, 2009.PMID 19178399
- [16]Gouel-Chéron A, Harpan A, Mertes PM, et al. Management of anaphylactic shock in the operating room Presse Med, 2016.PMID 27208918
- [17]Zheng F, Barthel G, Collange O, et al. Epinephrine, compared with arginine vasopressin, is associated with similar haemodynamic effects but significantly improved brain oxygenation in the early phase of anaphylactic shock in rats: An experimental study Eur J Anaesthesiol, 2015.PMID 26244468
- [18]Heyman HM, Serrano RA Vasoplegic Syndrome and Noncatecholamine Therapies 2026.PMID 38261707
- [19]Russell JA, Gordon AC, Williams MD, et al. Vasopressor Therapy in the Intensive Care Unit Semin Respir Crit Care Med, 2021.PMID 32820475
- [20]Thomas M, Crawford I Best evidence topic report. Glucagon infusion in refractory anaphylactic shock in patients on beta-blockers Emerg Med J, 2005.PMID 15788828
- [21]Oda Y, Yamasaki H, Osawa T, et al. Rescuing Protamine Anaphylaxis Refractory to Adrenaline Using Extracorporeal Membrane Oxygenation JACC Case Rep, 2025.PMID 40118612
- [22]Garcia-Mendez JP, Seelhammer TG, Wieruszewski PM, et al. VV-ECMO as a lifesaving measure for refractory bronchospasm in anaphylactic shock: A case report. Perfusion, 2026.PMID 41021782
- [23]Gorham NP Anaphylaxis:: After the Emergency Department Immunol Allergy Clin North Am, 2023.PMID 37394253
- [24]Wallace DV Knowledge gaps in the diagnosis and management of anaphylaxis Ann Allergy Asthma Immunol, 2023.PMID 37209836
- [25]Cardona V, Ansotegui IJ, Ebisawa M, et al. World allergy organization anaphylaxis guidance 2020 World Allergy Organ J, 2020.PMID 33204386
- [26]Jackson CA, et al. Retrospective comparison between 0.3 mg and 0.5 mg dosing of intramuscular epinephrine for anaphylaxis Am J Emerg Med, 2026.PMID 41106150
- [27]Dribin TE, et al. Anaphylaxis Clinical Care Pathway: Incorporating Intranasal Epinephrine (Adrenaline) J Allergy Clin Immunol Pract, 2026.PMID 42447993
- [28]Vitte J, et al. Use and Interpretation of Acute and Baseline Tryptase in Perioperative Hypersensitivity and Anaphylaxis J Allergy Clin Immunol Pract, 2021.PMID 33746087
- [29]Vitte J, et al. Paired acute-baseline serum tryptase levels in perioperative anaphylaxis: An observational study Allergy, 2019.PMID 30793322
- [30]Murakami Y, et al. Successful treatment of severe adrenaline-resistant anaphylactic shock with glucagon in a patient taking a beta-blocker: a case report JA Clin Rep, 2021.PMID 34907487
- [31]Rodrigues JM, et al. Methylene blue for clinical anaphylaxis treatment: a case report Sao Paulo Med J, 2007.PMID 17505688
- [32]Brown JC, et al. Epinephrine in the Management of Anaphylaxis J Allergy Clin Immunol Pract, 2020.PMID 32276687